Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells

Journal of Nutrition, Health and Aging

Volumn 19, Issue 2, 2015, Pages 123-129

  Li, W ^a   Jiang, M ^a   Xiao, Y ^a   Zhang, X ^a   Cui, S ^a   Huang, Guowei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Folic acid; methylation; protein phosphatase 2A; tau phosphorylation

Indexed keywords

FOLIC ACID; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2;

ALZHEIMER DISEASE; ARTICLE; CARBON METABOLISM; CELL VIABILITY; CONTROLLED STUDY; DEMETHYLATION; DEREGULATION; DOWN REGULATION; ENZYME INHIBITION; ENZYME REGULATION; FOLIC ACID DEFICIENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; METHYLATION; NEUROBLASTOMA; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ALZHEIMER DISEASE; CELL LINE, TUMOR; CELL SURVIVAL; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; METHYLATION; NEUROBLASTOMA; OKADAIC ACID; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; TAU PROTEINS;

EID: 84925487085     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-014-0514-4     Document Type: Article

References (36)

1. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Watanabe A, et al. Hyperphosphorylation of tau in PHF. Neurobiol Aging. 1995; 16(3): 365–371.
2. Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis. 2013; 33: S123–139.
3. Kimura T, Tsutsumi K, Taoka M, Saito T, Masuda-Suzukake M, Ishiguro K, et al. Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites. J Biol Chem. 2013; 288(11): 7968–7977.
4. Guo Q, Li H, Cole AL, Hur JY, Li Y, Zheng H. Modeling Alzheimer’s Disease in Mouse without Mutant Protein Overexpression: Cooperative and Independent Effects of Aβ and Tau. PLoS One. 2013; 8(11): e80706.
5. Tyagi E, Fiorelli T, Norden M, Padmanabhan J. Alpha 1-Antichymotrypsin, an Inflammatory Protein Overexpressed in the Brains of Patients with Alzheimer’s Disease, Induces Tau Hyperphosphorylation through c-Jun N-Terminal Kinase Activation. Int J Alzheimers Dis. 2013;2013:606083.
6. Yu Y, Run X, Liang Z, Li Y, Liu F, Liu Y, et al. Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases. J Neurochem. 2009; 108(6): 1480–1494.
7. Herzog F, Kahraman A, Boehringer D, Mak R, Bracher A, Walzthoeni T, et al. Structural probing of a protein phosphatase 2A network by chemical cross-linking and mass spectrometry. Science. 2012; 337(6100): 1348–1352.
8. Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Sun XY, et al. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiol Aging. 2013; 34(3): 745–756.
9. Sunahori K, Juang YT, Tsokos GC. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J Immunol. 2009; 182(3): 1500–1508.
10. Hwang JH, Jiang T, Kulkarni S, Faure N, Schaffhausen BS. Protein Phosphatase 2A Isoforms Utilizing Aβ Scaffolds Regulate Differentiation through Control of Akt Protein. J Biol Chem. 2013; 288(44): 32064–32073.
11. Yao XQ, Li XC, Zhang XX, Yin YY, Liu B, Luo DJ, et al. Glycogen synthase kinase-3β regulates leucine-309 demethylation of protein phosphatase-2A via PPMT1 and PME-1. FEBS Lett. 2012; 586(16): 2522–2528.
12. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Speciale S, et al. Altered expression levels of the protein phosphatase 2A ABαC enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol. 2004; 63(4): 287–301.
13. Bryant JC, Westphal RS, Wadzinski BE. Methylated C-terminal leucine residue of PP2A catalytic subunit is important for binding of regulatory Balpha subunit. Biochem J. 1999; 339 (Pt 2): 241–246.
14. Ikehara T, Ikehara S, Imamura S, Shinjo F, Yasumoto T. Methylation of the Cterminal leucine residue of the PP2A catalytic subunit is unnecessary for the catalytic activity and the binding of regulatory subunit (PR55/B). Biochem Biophys Res Commun. 2007; 354(4): 1052–1057.
15. Herrmann W, Obeid R. Biomarkers of folate and vitamin B(12) status in cerebrospinal fluid. Clin Chem Lab Med. 2007; 45(12): 1614–1620.
16. Fuso A, Nicolia V, Ricceri L, Cavallaro RA, Isopi E, Mangia F, et al. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice. Neurobiol Aging. 2012; 33(7): 1482.e1–16.
17. Arlt S, Schwedhelm E, Kölsch H, Jahn H, Linnebank M, Smulders Y, et al. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer’s disease. J Alzheimers Dis. 2012; 31(4): 751–758.
18. Teng YW, Cerdena I, Zeisel SH. Homocysteinemia in mice with genetic betaine homocysteine S-methyltransferase deficiency is independent of dietary folate intake. J Nutr. 2012; 142(11): 1964–1967.
19. Luo S, Zhang X, Yu M, Yan H, Liu H, Wilson JX, et al. Folic acid acts through DNA methyltransferases to induce the differentiation of neural stem cells into neurons. Cell Biochem Biophys. 2013; 66(3): 559–566.
20. Yang YH, Hsieh TJ, Tsai ML, Chen CH, Lin HT, Wu SJ. Neuroprotective effects of Hu-Yi-Neng, a diet supplement, on SH-SY5Y human neuroblastoma cells. J Nutr Health Aging. 2014;18(2):184–90.
21. Jiménez-Redondo S, Beltrán de Miguel B, Gavidia Banegas J, Guzmán Mercedes L, Gómez-Pavón J, Cuadrado Vives C. Influence of nutritional status on health-related quality of life of non-institutionalized older people. J Nutr Health Aging. 2014;18(4):359–64.
22. Chai GS, Jiang X, Ni ZF, Ma ZW, Xie AJ, Cheng XS, et al. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem. 2013; 124(3): 388–396.
23. Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, et al. Homocysteinemediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 2007;26(8):603–11.
24. Baharians Z, Schönthal AH. Autoregulation of protein phosphatase type 2A expression. J Biol Chem. 1998; 273(30):19019–24.
25. Iqbal K, Gong CX, Liu F. Hyperphosphorylation-induced tau oligomers. Front Neurol. 2013;4:112.
26. Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, Iqbal K, et al. Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer’s disease patients: an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay. Am J Pathol. 2002; 160(4):1269–1278.
27. Bottiglieri T, Arning E, Wasek B, Nunbhakdi-Craig V, Sontag JM, Sontag E. Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain. J Neurosci. 2012; 32(27):9173–9181.
28. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, et al. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement. 2013;18. pii: S1552-5260(13)02464-3.
29. Wei W, Liu YH, Zhang CE, Wang Q, Wei Z, Mousseau DD, et al. Folate/vitamin-B12 prevents chronic hyperhomocysteinemia-induced tau hyperphosphorylation and memory deficits in aged rats. J Alzheimers Dis. 2011; 27(3): 639–650.
30. Broersen LM, Kuipers AA, Balvers M, van Wijk N, Savelkoul PJ, de Wilde MC, et al. A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AβPPswe/PS1dE9 mice. J Alzheimers Dis. 2013; 33(1): 177–190.
31. Sutter BM, Wu X, Laxman S, Tu BP. Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A. Cell. 2013; 154(2): 403–415.
32. Grillo MA, Colombatto S. S-adenosylmethionine and its products. Amino Acids. 2008; 34(2): 187–193.
33. Jiang Y, Zhang H, Sun T, Wang J, Sun W, Gong H, et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. Acta Biochim Biophys Sin (Shanghai). 2012; 44(10): 866–875.
34. Ali F, Ranneh Y, Ismail A, Vaes B. Impaired of a non-DNA dependent methylation status decides the fat decision of bone marrow-derived C3H10T1/2 stem cell. Springerplus. 2013; 2:590.
35. Yoon SY, Choi HI, Choi JE, Sul CA, Choi JM, Kim DH. Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. Biochem Biophys Res Commun. 2007; 363(3): 811–816.
36. Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010; 7(8): 656–664.